NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

穿戴式皮下輸液設備

Wearable Subcutaneous Infusion Systems

出版商 Greystone Research Associates 商品編碼 974142
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
穿戴式皮下輸液設備 Wearable Subcutaneous Infusion Systems
出版日期: 2020年12月07日內容資訊: 英文
簡介

本報告提供穿戴式皮下輸液設備調查分析,上市/開發中的產品,供應商,設備詳細內容,治療市場,市場動態,主要企業等相關的系統性資訊。

目錄

摘要整理

可注射/可注入的市場區隔趨勢

  • 醫藥品開發趨勢
  • 藥物輸送設備的演進
  • 患者的自我給藥趨勢
  • 實行技術
  • 冷凍乾燥醫藥品/重組

皮下輸液設備:設計要素

  • 數量、粘度
  • 一次包裝
  • 注射方法
  • 設備電子產品

皮下注射設備:市場區隔

  • 門診病人的注射經費、物流的負擔
  • 生技藥品
  • 大容量的醫藥品
  • 期間依賴的給藥藥

皮下輸液設備:12個已通過核准設備分析

  • 行動方式
  • 設備類型
  • 注射事件
  • 主要容器
  • 醫藥品途徑
  • 容量
  • 醫藥品菲爾
  • 連接性
  • 安全功能

市場要素

  • 自我給藥和病人依從性
  • 法規指導和產品核可
  • 醫療的經濟學
  • 醫藥品的差異化

市場參與企業的簡介

目錄
Product Code: WSJ695K

Converging Factors Driving the Growth of Subcutaneous Infusion

As currently formulated, a significant number of therapeutic drugs require dosage volumes or possess viscosities well in excess of the upper range for traditional subcutaneous delivery. These drugs are currently delivered via infusion. The demographics of patient populations and the current trend in therapeutic drug development are converging to create an increasingly steep demand curve for infusion. The costs and logistics of this convergence are a major driver of the energy behind small form factor subcutaneous infusion devices. As the adoption of and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. This dramatic shift in healthcare delivery is creating a need for devices that mask an underlying layer of complexity via design initiatives that are patient friendly.

What You Will Learn:

  • What subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by wearable infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for subcutaneous infusion systems?
  • What are the major factors that will drive wearable subcutaneous infusion systems demand?
  • What is the addressable market for wearable subcutaneous infusion systems?
  • What is the expected impact of subcutaneous infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Table of Contents

Executive Summary

Injectable/Infusible Market Segment Dynamics

  • Drug Development Trends
  • Drug Delivery Device Evolution
  • The Trend toward Patient Self-Administration
  • Enabling Technology
  • Lyophilized Drugs/Reconstitution

Subcutaneous Infusion Systems - Design Factors

  • Volumes and Viscosities
  • Primary Packaging
  • Injection Method
  • Device Electronics

Subcutaneous Infusion Devices - Market Segments

  • The Cost and Logistical Burden of Out-patient Infusion
  • Biologicals
  • High Volume Drugs
  • Duration Dependent Administration Drugs

Subcutaneous Infusion Systems - Analysis of 12 Approved Devices

  • Mode of Operation
  • Device Type
  • Injection Event
  • Primary Container
  • Drug Path
  • Capacity
  • Drug Fill
  • Connectivity
  • Safety Features

Market Factors

  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • Healthcare Economics
  • Drug Product Differentiation

Market Participant Profiles